Daniel Patrick O'Day
Chairman & CEO · Gilead Sciences, Inc. (GILD)
sold: $27,241,124
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 5, 2026 | Sale 10b5-1 plan | 112,429 | $175.16 | $19,693,439 | SEC |
| November 2, 2026 | Sale 10b5-1 plan | 30,881 | $172.57 | $5,329,178 | SEC |
| October 1, 2026 | Sale 10b5-1 plan | 15,000 | $147.90 | $2,218,508 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
